Hims & Hers Health Inc (HIMS) (Q3 2026) Earnings Call Highlights: Revenue Surges 49%
Hims & Hers Health Inc. (HIMS) reported Q3 2026 revenue growth of 49%, but subscribers declined by 100,000 to 2.8 million due to reduced marketing. Gross margins fell to 57%, and GAAP net loss was $33 million. Full-year adjusted EBITDA guidance was lowered to $257-$277 million. The company plans to increase marketing and expects subscriber growth to recover in Q1 2027. Management discussed strategic shifts, including peptide launches and international expansion.
How this was made
The 30-second read
Why it matters
The guidance cut and subscriber decline are fresh, primary disclosures that will likely drive the stock lower in the immediate trading session.
Market read
HIMS stock is expected to face downside pressure as investors digest weaker guidance and subscriber headwinds.
What to watch
Potential upside from upcoming Lilly GLP‑1 products and AI‑driven app improvements may offset near‑term guidance weakness.
Background
Hims & Hers reported a 49% revenue surge year‑over‑year but highlighted subscriber loss and a guidance reduction for FY 2026.
Ticker impact
Q3 2026 earnings call disclosed a $20M revenue hit, subscriber loss of 100k and a lowered full‑year adjusted EBITDA guidance to $257‑$277M.
likely pressure as the market prices in weaker guidance and subscriber headwinds
Earnings guidance is a primary disclosure; the cut is material for a growth‑stage company and will likely trigger sell‑offs.
Market effects
Weight‑loss and tele‑health subsectors may see broader scrutiny as Hims & Hers signals slower subscriber growth.
International expansion costs could weigh on other U.S. tele‑health peers with overseas exposure.
Limited; impact confined mainly to U.S. consumer health and digital health stocks.
Counterpoint
If the marketing pullback successfully improves CAC and retention, the short‑term dip could be over‑stated.
Key entities
- CEOAndrew Dudum
Provided commentary on marketing strategy and upcoming product launches.
- CFOYemi Okupe
Outlined the financial impact of marketing pullback and guidance reduction.
